{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:22:59Z","timestamp":1781497379940,"version":"3.54.1"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T00:00:00Z","timestamp":1534982400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0202575","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T13:44:57Z","timestamp":1535031897000},"page":"e0202575","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":49,"title":["Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: Nationwide pharmacoepidemiological study"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3072-5697","authenticated-orcid":true,"given":"Sasha","family":"Gulati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Solheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven M.","family":"Carlsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise R.","family":"\u00d8ie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Jensberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1543-6056","authenticated-orcid":true,"given":"Agnete M.","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattis A.","family":"Madsbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampis","family":"Giannadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asgeir S.","family":"Jakola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8yvind","family":"Salvesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,8,23]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1212\/WNL.0b013e31829e6eff","article-title":"Mortality after hemorrhagic stroke: data from general practice (The Health Improvement Network)","volume":"81","author":"A Gonzalez-Perez","year":"2013","journal-title":"Neurology"},{"key":"ref2","article-title":"Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants","author":"JC Purrucker","year":"2015","journal-title":"JAMA Neurol"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1371\/journal.pctr.0010009","article-title":"Factors that can affect the external validity of randomised controlled trials","volume":"1","author":"PM Rothwell","year":"2006","journal-title":"PLoS Clin Trials"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1001\/jamainternmed.2014.5398","article-title":"Risk of bleeding with dabigatran in atrial fibrillation","volume":"175","author":"I Hernandez","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"9706","key":"ref5","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/S0140-6736(09)61751-7","article-title":"Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data","volume":"374","author":"R Sorensen","year":"2009","journal-title":"Lancet"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000487518","article-title":"Epidemiology of Intracranial Hemorrhage Associated with Oral Anticoagulants in Spain: Trends in Anticoagulation Complications Registry\u2014The TAC 2 Study","volume":"7","author":"G Zapata-Wainberg","year":"2018","journal-title":"Interventional neurology"},{"issue":"6","key":"ref7","article-title":"Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation","volume":"5","author":"X Yao","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.12688\/f1000research.7633.1","article-title":"Risk of intracranial hemorrhage in users of oral antithrombotic drugs: Study protocol for a nationwide study","volume":"4","author":"S Gulati","year":"2015","journal-title":"F1000Research"},{"key":"ref9","unstructured":"Norwegian Institute of Public Health. Over the counter medications in Norway 2017. https:\/\/www.fhi.no\/hn\/legemiddelbruk\/omsetning-utenom-apotek\/stabilt-butikksalg-av-reseptfrie-legemidler\/<\/ext-link>."},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/1403494815621641","article-title":"Comparison of the validity of stroke diagnoses in a medical quality register and an administrative health register","volume":"44","author":"T Varmdal","year":"2016","journal-title":"Scand J Public Health"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"e00900","DOI":"10.1002\/brb3.900","article-title":"Validation of intracranial hemorrhage in the Norwegian Patient Registry","volume":"8","author":"LR Oie","year":"2018","journal-title":"Brain Behav"},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/pds.4058","article-title":"Subdural hematoma cases identified through a Danish patient register: diagnosis validity, clinical characteristics, and preadmission antithrombotic drug use","volume":"25","author":"FR Poulsen","year":"2016","journal-title":"Pharmacoepidemiology and drug safety"},{"key":"ref13","unstructured":"Guidelines for ATC classification and DDD assignment 2015. WHO Collaborating Centre for Drug Statistics Methodology. Oslo, 2014."},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"SJ Connolly","year":"2009","journal-title":"N Engl J Med"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"CB Granger","year":"2011","journal-title":"N Engl J Med"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"MR Patel","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1502000","article-title":"Idarucizumab for Dabigatran Reversal","volume":"373","author":"CV Pollack Jr.","year":"2015","journal-title":"N Engl J Med"},{"key":"ref18","article-title":"Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors","author":"SJ Connolly","year":"2016","journal-title":"N Engl J Med"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1161\/CIRCULATIONAHA.107.181940","article-title":"ACC\/AHA 2007 guidelines for the management of patients with unstable angina\/non ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina\/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine","volume":"116","author":"JL Anderson","year":"2007","journal-title":"Circulation"},{"issue":"13","key":"ref20","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/eurheartj\/ehm161","article-title":"Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes","volume":"28","author":"JP Bassand","year":"2007","journal-title":"Eur Heart J"},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1161\/CIRCULATIONAHA.106.177292","article-title":"ACC\/AHA\/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society","volume":"114","author":"V Fuster","year":"2006","journal-title":"Circulation"},{"issue":"23","key":"ref22","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/eurheartj\/ehn416","article-title":"Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology","volume":"29","author":"F Van de Werf","year":"2008","journal-title":"Eur Heart J"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.thromres.2014.10.016","article-title":"Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome","volume":"135","author":"OO Braun","year":"2015","journal-title":"Thromb Res"},{"issue":"9872","key":"ref24","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial","volume":"381","author":"WJ Dewilde","year":"2013","journal-title":"Lancet"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.000989","article-title":"Use of aspirin for primary and secondary cardiovascular disease prevention in the United States, 2011\u20132012","volume":"3","author":"AG Mainous","year":"2014","journal-title":"Journal of the American Heart Association"},{"issue":"7","key":"ref26","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jama.2016.8362","article-title":"Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease: Shared Decision Making in Clinical Practice","volume":"316","author":"S Mora","year":"2016","journal-title":"JAMA: the journal of the American Medical Association"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1212\/WNL.0b013e31829e6ffa","article-title":"Antithrombotic drugs and risk of hemorrhagic stroke in the general population","volume":"81","author":"LA Garcia-Rodriguez","year":"2013","journal-title":"Neurology"},{"issue":"16","key":"ref28","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"DL Bhatt","year":"2006","journal-title":"N Engl J Med"},{"issue":"9431","key":"ref29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"HC Diener","year":"2004","journal-title":"Lancet"},{"issue":"1\u20132","key":"ref30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"HC Diener","year":"1996","journal-title":"J Neurol Sci"},{"issue":"9523","key":"ref31","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(06)68734-5","article-title":"Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial","volume":"367","author":"PH Halkes","year":"2006","journal-title":"Lancet"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","article-title":"Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke","volume":"359","author":"RL Sacco","year":"2008","journal-title":"N Engl J Med"},{"issue":"8","key":"ref33","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/jama.2017.0639","article-title":"Association of Antithrombotic Drug Use With Subdural Hematoma Risk","volume":"317","author":"D Gaist","year":"2017","journal-title":"JAMA: the journal of the American Medical Association"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/TA.0b013e3182aa80f9","article-title":"Effects of anticoagulant and antiplatelet drugs on the risk for hospital admission for traumatic injuries: a case-control and population-based study","volume":"76","author":"S Di Bartolomeo","year":"2014","journal-title":"The journal of trauma and acute care surgery"},{"issue":"9","key":"ref35","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.injury.2009.05.006","article-title":"Patterns of mortality and causes of death in polytrauma patients\u2014has anything changed?","volume":"40","author":"R Pfeifer","year":"2009","journal-title":"Injury"},{"issue":"8","key":"ref36","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/STROKEAHA.115.009087","article-title":"Antithrombotic Treatment Following Intracerebral Hemorrhage in Patients With and Without Atrial Fibrillation","volume":"46","author":"J Pennlert","year":"2015","journal-title":"Stroke"},{"issue":"9","key":"ref37","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1161\/STR.0b013e3181ec611b","article-title":"Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"41","author":"LB Morgenstern","year":"2010","journal-title":"Stroke"},{"issue":"7","key":"ref38","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/ijs.12309","article-title":"European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage","volume":"9","author":"T Steiner","year":"2014","journal-title":"Int J Stroke"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1755-5922.2009.00118.x","article-title":"Systematic review of observational research studying the long-term use of antithrombotic medicines following intracerebral hemorrhage","volume":"28","author":"RW Flynn","year":"2010","journal-title":"Cardiovasc Ther"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/ana.25079","article-title":"Oral Anticoagulation and Functional Outcome after Intracerebral Hemorrhage","volume":"82","author":"A Biffi","year":"2017","journal-title":"Ann Neurol"},{"issue":"12","key":"ref41","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1160\/TH17-05-0342","article-title":"Low-Dose Aspirin after an Episode of Haemorrhagic Stroke Is Associated with Improved Survival","volume":"117","author":"A Gonzalez-Perez","year":"2017","journal-title":"Thromb Haemost"},{"key":"ref42","first-page":"Cd012144","article-title":"Antithrombotic treatment after stroke due to intracerebral haemorrhage","volume":"5","author":"LA Perry","year":"2017","journal-title":"The Cochrane database of systematic reviews"},{"key":"ref43","article-title":"Bleeding complications related to warfarin treatment: a descriptive register study from the anticoagulation clinic at Helsingborg Hospital","author":"M Navgren","year":"2013","journal-title":"J Thromb Thrombolysis"},{"issue":"14","key":"ref44","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJMp1302834","article-title":"Dabigatran and postmarketing reports of bleeding","volume":"368","author":"MR Southworth","year":"2013","journal-title":"N Engl J Med"},{"issue":"19","key":"ref45","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"AJ Camm","year":"2010","journal-title":"European heart journal"},{"issue":"5","key":"ref46","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"R Pisters","year":"2010","journal-title":"Chest"},{"issue":"8","key":"ref47","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/jama.2015.0809","article-title":"Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction","volume":"313","author":"AM Schjerning Olsen","year":"2015","journal-title":"JAMA"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0202575","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T17:21:28Z","timestamp":1571764888000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0202575"}},"subtitle":[],"editor":[{"given":"Thanh G","family":"Phan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,8,23]]},"references-count":47,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0202575","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,23]]}}}